Kalvista Pharmaceuticals (KALV) PT Lowered to $28 at Citizens - 'Performance in line'

March 26, 2026 4:38 AM

Citizens analyst Jonathan Wolleben lowered the price target on Kalvista Pharmaceuticals Inc (NASDAQ: KALV) to $28.00 (from $29.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found